Senna (Cassia angustifolia)

Senna (Cassia angustifolia) contains sennosides that stimulate colonic contractions and promote bowel movements through irritation of intestinal mucosa. The plant also demonstrates alpha-glucosidase inhibition potential in laboratory studies, suggesting possible blood sugar management effects.

Origin & History

Senna (Cassia angustifolia) is a medicinal plant native to regions including Iran, with dried leaves sourced from traditional medicinal plant markets and botanically authenticated before processing. The plant material is processed through extraction methods including methanol-water (80:20) maceration for 72 hours, followed by rotary evaporation and freeze-drying, or water leaching with membrane filtration and spray drying to produce standardized extracts containing anthraquinone glycosides, particularly sennosides.

Historical & Cultural Context

Senna leaves are sourced from Iranian medicinal plant markets, suggesting historical use in regional traditional medicine systems. However, the research provides no specific details about traditional applications, historical duration of use, or cultural significance within Unani or other traditional medicine frameworks.

Health Benefits

• Alpha-glucosidase inhibition potential shown in vitro (hexane and crude extracts), though no human clinical evidence available
• Traditional laxative effects implied by sennoside content (0.43±0.01 mg/g), but no clinical trials provided
• Phenolic content in ethyl acetate fractions (382.25 μg/mL gallic acid equivalents) suggests antioxidant potential, though unverified in humans
• Limited evidence quality - all benefits based on in vitro studies or traditional use assumptions
• No clinical trials, RCTs, or meta-analyses available to support health claims

How It Works

Sennosides, the primary bioactive compounds, are metabolized by colonic bacteria into rhein anthrone, which irritates the intestinal mucosa and stimulates peristaltic contractions. The hexane and crude extracts demonstrate alpha-glucosidase enzyme inhibition in vitro, potentially reducing carbohydrate digestion and glucose absorption. Phenolic compounds in ethyl acetate fractions may contribute additional antioxidant activity.

Scientific Research

The research dossier reveals a complete absence of human clinical trials, randomized controlled trials (RCTs), or meta-analyses for Senna (Cassia angustifolia). Available data is limited to in vitro enzyme inhibition studies (α-glucosidase inhibition compared to acarbose) and analytical validation of sennoside B content (0.43±0.01 mg/g via UPLC-ESI-MRM/MS), with no PubMed PMIDs provided for clinical studies.

Clinical Summary

Current evidence is limited to in vitro studies showing alpha-glucosidase inhibition activity in hexane and crude extracts. No human clinical trials have been conducted to validate the traditional laxative effects or blood sugar management properties. The sennoside content has been quantified at 0.43±0.01 mg/g in laboratory analysis. Clinical research is needed to establish safety, efficacy, and optimal dosing protocols.

Nutritional Profile

Senna (Cassia angustifolia) is used medicinally rather than as a dietary food source, so macronutrient profiling is limited. Bioactive compounds are the primary nutritional focus: Sennosides (anthraquinone glycosides) measured at 0.43±0.01 mg/g dry weight, comprising primarily sennoside A and sennoside B as the principal laxative constituents. Total phenolic content varies by extraction fraction — ethyl acetate fraction yields approximately 382.25 μg/mL gallic acid equivalents, indicating moderate-to-high polyphenol concentration; hexane and crude extracts show comparatively lower phenolic density. Flavonoid compounds including kaempferol and its glycosides are present, alongside isorhamnetin and quercetin derivatives. Anthraquinones beyond sennosides include rhein, aloe-emodin, and chrysophanol at trace levels. Crude fiber content in dried leaf material is estimated at 10–15% of dry weight based on genus-level data. Protein content is low, approximately 10–13% of dry weight in raw leaf. Mineral content includes potassium, calcium, and magnesium at concentrations typical of dried leguminous leaves, though precise values for C. angustifolia specifically are not well-documented in isolation. Bioavailability note: Sennosides are poorly absorbed in the small intestine and require colonic bacterial hydrolysis to active rhein-anthrone metabolites, explaining the delayed laxative onset of 6–12 hours. Phenolic bioavailability is extraction-method dependent, with ethyl acetate fractions showing superior in vitro activity over hexane fractions.

Preparation & Dosage

No clinically studied dosage ranges are available from human trials. Analytical studies report sennoside B content at 0.43±0.01 mg/g in leaf extracts and 1.525% in ethyl acetate fractions per ASEAN-herbal-medicine standards, but without associated therapeutic dosing guidelines. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient research to determine synergistic ingredients

Safety & Interactions

Long-term use of senna can cause electrolyte imbalances, dependency, and colonic atony due to chronic stimulation of bowel contractions. Senna may interact with digoxin by reducing potassium levels and with anticoagulants by affecting vitamin K absorption. Contraindicated in pregnancy, breastfeeding, and individuals with inflammatory bowel diseases or intestinal obstruction. Short-term use under medical supervision is generally considered safer than prolonged consumption.